Nivolumab versus Nivolumab Combined with Ipilimumab in Patients with Melanoma Brain Metastases - 100459

Spotlight
Video

Nivolumab versus Nivolumab Combined with Ipilimumab in Patients with Melanoma Brain Metastases

moasc has 295 videos Subscribe Here

Loading........
Description: Daniela Bota, MD of UC Irvine Health discusses the results of nivolumab versus nivolumab plus ipilimumab in patients with Melanoma at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.

Abstract 9508: A Randomized Phase II Study of Nivolumab or Nivolumab Combined with Ipilimumab in Patients (pts) with Melanoma Brain Metastases (mets): The Anti-PD1 Brain Collaboration (ABC)
Shared By : moasc
Posted on : 08/03/17
Added : 9 months ago